Granahan Investment Management - CYTOMX THERAPEUTICS INC ownership

CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 63 filers reported holding CYTOMX THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.10 and the average weighting 0.0%.

Quarter-by-quarter ownership
Granahan Investment Management ownership history of CYTOMX THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$1,829,000
-16.6%
279,218
-15.3%
0.04%
-44.6%
Q3 2020$2,192,000
-26.5%
329,556
-8.0%
0.07%
-31.5%
Q2 2020$2,983,000
+46.4%
358,122
+34.8%
0.11%
-1.8%
Q1 2020$2,038,000
+59.5%
265,673
+72.7%
0.11%
+86.4%
Q4 2019$1,278,000
+12.9%
153,818
+0.3%
0.06%
-4.8%
Q3 2019$1,132,000
-31.5%
153,397
+4.2%
0.06%
-24.4%
Q2 2019$1,652,000
-1.7%
147,223
-5.9%
0.08%
-8.9%
Q1 2019$1,681,000
-31.9%
156,391
-4.4%
0.09%
-48.6%
Q4 2018$2,470,000
-20.1%
163,547
-2.1%
0.18%
+4.2%
Q3 2018$3,091,000
-16.8%
167,088
+2.8%
0.17%
-25.0%
Q2 2018$3,715,000
-19.7%
162,504
-0.1%
0.22%
-32.9%
Q1 2018$4,626,000
+140.4%
162,592
+78.4%
0.33%
+121.2%
Q4 2017$1,924,00091,1440.15%
Other shareholders
CYTOMX THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 6,450,000$8,320,5001.17%
BVF INC/IL 6,595,801$8,508,5830.23%
Bronte Capital Management Pty Ltd. 925,245$1,193,5660.12%
Formidable Asset Management, LLC 318,111$410,3630.09%
Congress Park Capital LLC 112,450$145,0610.08%
Forefront Analytics, LLC 49,421$63,7540.04%
Ground Swell Capital, LLC 10,966$14,1460.02%
Clearline Capital LP 196,583$253,5920.02%
CORNERCAP INVESTMENT COUNSEL INC 81,352$104,9440.02%
ACADIAN ASSET MANAGEMENT LLC 2,646,190$3,4120.01%
View complete list of CYTOMX THERAPEUTICS INC shareholders